CONWAY — Businesswoman, mother and New York Times best-selling author turned Democratic congressional hopeful Stefany Shaheen came to North Co…
Scientists discovered that a medication traditionally prescribed to treat diabetes has been linked to lower risks of dementia and early death.
Eating three servings of French fries a week is associated with a 20% increased risk of developing type 2 diabetes.
Northwell Health reports on five surprising heart health risks, including that young people can have heart attacks and sleep quality matters.
Doctors stress that the teenage years are the "most critical" for building lifelong bone strength.
Knowable Magazine reports that worm-inspired treatments show promise for metabolic diseases by reducing inflammation and improving insulin sensitivity.
GoodRx reports GLP-1 weight-loss pills are emerging, with candidates like orforglipron and oral semaglutide likely to gain FDA approval by 2026.
Researchers found that the active ingredient in Ozempic may lower the risk of dementia in people with type 2 diabetes.
GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make the process of switching from a compounded GLP-1 to a brand-name GLP-1 smoother, safer, and more affordable.